Flagship Pioneering, LLC Long-Term Concentrated

CIK: 0001400240 · Show all filings

Period: Q3 2022 (← Previous) (Next →)

Filing Date: Nov 14, 2022

Total Value ($000): $2,375,805 (100.0% shares, 0.0% debt)

Holdings (12)

MRNA Moderna Inc 64.1%

Value ($000) $1,523,857 Shares 12,886,743 Est. Cost $16.43 Unrealized +823.3%

SANA Sana Biotechnology Inc 8.6%

Value ($000) $205,434 Shares 34,239,018 Est. Cost $32.56 Unrealized -77.8%

— Seres Therapeutics Inc 6.2%

Value ($000) $148,411 Shares 23,117,045 Est. Cost $7.75 Unrealized —

— Omega Therapeutics Inc 5.9%

Value ($000) $140,391 Shares 25,902,269 Est. Cost $18.85 Unrealized —

FHTX Foghorn Therapeutics Inc 4.6%

Value ($000) $108,744 Shares 12,674,120 Est. Cost $19.16 Unrealized -32.8%

— Evelo Biosciences Inc 4.4%

Value ($000) $105,393 Shares 50,427,328 Est. Cost $5.89 Unrealized —

DNLI Denali Therapeutics Inc 3.4%

Value ($000) $80,407 Shares 2,619,968 Est. Cost $17.97 Unrealized +80.9%

— Axcella Health Inc 1.4%

Value ($000) $32,264 Shares 18,867,785 Est. Cost $6.29 Unrealized —

— Rubius Therapeutics Inc 0.7%

Value ($000) $16,557 Shares 38,506,526 Est. Cost $24.00 Unrealized —

SYRS Syros Pharmaceuticals Inc 0.3%

Value ($000) $6,400 Shares 993,848 Est. Cost $8.12 Unrealized 0.0%

— Sigilon Therapeutics Inc 0.2%

Value ($000) $5,185 Shares 10,370,369 Est. Cost $48.03 Unrealized —

— Codiak Biosciences Inc 0.1%

Value ($000) $2,762 Shares 3,540,636 Est. Cost $23.99 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
MRNA	Moderna Inc	12,886,743	$1,523,857	64.1%	$16.43	+823.3%	COM	60770K107
SANA	Sana Biotechnology Inc	34,239,018	$205,434	8.6%	$32.56	-77.8%	COM	799566104
—	Seres Therapeutics Inc	23,117,045	$148,411	6.2%	$7.75	—	COM	81750R102
—	Omega Therapeutics Inc	25,902,269	$140,391	5.9%	$18.85	—	COM	68217N105
FHTX	Foghorn Therapeutics Inc	12,674,120	$108,744	4.6%	$19.16	-32.8%	COM	344174107
—	Evelo Biosciences Inc	50,427,328	$105,393	4.4%	$5.89	—	COM	299734103
DNLI	Denali Therapeutics Inc	2,619,968	$80,407	3.4%	$17.97	+80.9%	COM	24823R105
—	Axcella Health Inc	18,867,785	$32,264	1.4%	$6.29	—	COM	05454B105
—	Rubius Therapeutics Inc	38,506,526	$16,557	0.7%	$24.00	—	COM	78116T103
SYRS	Syros Pharmaceuticals Inc	993,848	$6,400	0.3%	$8.12	0.0%	COM	87184Q206
—	Sigilon Therapeutics Inc	10,370,369	$5,185	0.2%	$48.03	—	COM	82657L107
—	Codiak Biosciences Inc	3,540,636	$2,762	0.1%	$23.99	—	COM	192010106